Byron J. Hoogwerf, MD
Department of Endocrinology, Director, Internal Medicine Residency Program, Cleveland Clinic; investigator, Heart Outcomes Prevention Evaluation (HOPE) study

James B. Young, MD
Head, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiology, Cleveland Clinic; member, steering committee, Heart Outcomes Prevention Evaluation (HOPE) study

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses off-label uses of medication. The HOPE study was funded by the Medical Research Council of Canada, Hoechst-Marion Roussel, AstraZeneca, King Pharmacuticals, Natural Source Vitamin E Association, Negma, and the Heart and Stroke Foundation of Ontario.

Drs. Hoogwerf and Young serve as consultants for Monarch Pharmaceuticals.

Byron J. Hoogwerf, MD
Department of Endocrinology, Director, Internal Medicine Residency Program, Cleveland Clinic; investigator, Heart Outcomes Prevention Evaluation (HOPE) study

James B. Young, MD
Head, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiology, Cleveland Clinic; member, steering committee, Heart Outcomes Prevention Evaluation (HOPE) study

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses off-label uses of medication. The HOPE study was funded by the Medical Research Council of Canada, Hoechst-Marion Roussel, AstraZeneca, King Pharmacuticals, Natural Source Vitamin E Association, Negma, and the Heart and Stroke Foundation of Ontario.

Drs. Hoogwerf and Young serve as consultants for Monarch Pharmaceuticals.

Byron J. Hoogwerf, MD
Department of Endocrinology, Director, Internal Medicine Residency Program, Cleveland Clinic; investigator, Heart Outcomes Prevention Evaluation (HOPE) study

James B. Young, MD
Head, Section of Heart Failure and Cardiac Transplant Medicine, Department of Cardiology, Cleveland Clinic; member, steering committee, Heart Outcomes Prevention Evaluation (HOPE) study

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

This paper discusses off-label uses of medication. The HOPE study was funded by the Medical Research Council of Canada, Hoechst-Marion Roussel, AstraZeneca, King Pharmacuticals, Natural Source Vitamin E Association, Negma, and the Heart and Stroke Foundation of Ontario.

Drs. Hoogwerf and Young serve as consultants for Monarch Pharmaceuticals.

James T. Mayes, MD
Department of General Surgery, Cleveland Clinic

Vincent W. Dennis, MD
Chairman, Hypertension and Nephrology, Cleveland Clinic

Byron J. Hoogwerf, MD
Transplantation Center and Department of Endocrinology, Cleveland Clinic

Address: James T. Mayes, MD, Department of General Surgery, A110, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

James T. Mayes, MD
Department of General Surgery, Cleveland Clinic

Vincent W. Dennis, MD
Chairman, Hypertension and Nephrology, Cleveland Clinic

Byron J. Hoogwerf, MD
Transplantation Center and Department of Endocrinology, Cleveland Clinic

Address: James T. Mayes, MD, Department of General Surgery, A110, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

James T. Mayes, MD
Department of General Surgery, Cleveland Clinic

Vincent W. Dennis, MD
Chairman, Hypertension and Nephrology, Cleveland Clinic

Byron J. Hoogwerf, MD
Transplantation Center and Department of Endocrinology, Cleveland Clinic

Address: James T. Mayes, MD, Department of General Surgery, A110, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; [email protected]

Ivan P. Casserly
Department of Cardiology, Cleveland Clinic

Philippe L. L'Allier
Department of Cardiology, Cleveland Clinic

Murat E. Tuzcu, MD
Director, Intravascular Ultrasound Care Laboratory, Department of Cardiology, Cleveland Clinic

Address: Murat E. Tuzcu, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, [email protected]

Ivan P. Casserly
Department of Cardiology, Cleveland Clinic

Philippe L. L'Allier
Department of Cardiology, Cleveland Clinic

Murat E. Tuzcu, MD
Director, Intravascular Ultrasound Care Laboratory, Department of Cardiology, Cleveland Clinic

Address: Murat E. Tuzcu, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, [email protected]

Ivan P. Casserly
Department of Cardiology, Cleveland Clinic

Philippe L. L'Allier
Department of Cardiology, Cleveland Clinic

Murat E. Tuzcu, MD
Director, Intravascular Ultrasound Care Laboratory, Department of Cardiology, Cleveland Clinic

Address: Murat E. Tuzcu, MD, Department of Cardiology, F25, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, [email protected]

Alan J. Taege, MD
Department of Infectious Diseases, Cleveland Clinic

Alan J. Taege, MD
Department of Infectious Diseases, Cleveland Clinic

Alan J. Taege, MD
Department of Infectious Diseases, Cleveland Clinic

Alan J. Taege, MD
Department of Infectious Diseases, Cleveland Clinic

Alan J. Taege, MD
Department of Infectious Diseases, Cleveland Clinic

Alan J. Taege, MD
Department of Infectious Diseases, Cleveland Clinic